FDA Inspection 1239352 — American CryoStem Corporation

American CryoStem Corporation — FEI 3008307548

The FDA completed an inspection of American CryoStem Corporation on May 22, 2024 in Monmouth Junction, NJ. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
May 22, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Monmouth Junction, NJ (United States)

Citations

IDCFRDescription
1235921 CFR 1271.195(a)(3)Aseptic processing---cleaning, disinfecting
1237521 CFR 1271.210(a)Use prior to verification